They suggested that HO-1 through DNMT1 reduces p15 expression, as DNMT1 blocking attenuated the effect of HO-1 on p15 expression and HO-1 inhibition reduced the expression of DNMT1 in MDS cells. Here, CDKN2B is linked to myelodysplastic syndrome.